Security key
31189P102
FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE)
CUSIP: 31189P102
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 122,342,805
- Total 13F shares
- 114,626,757
- Share change
- -7,789,527
- Total reported value
- $401,134,107
- Put/Call ratio
- 17%
- Price per share
- $3.50
- Number of holders
- 157
- Value change
- -$26,268,311
- Number of buys
- 55
- Number of sells
- 93
Report period
Q3 2024
Institutions
157
Top holders
10
FATE full security history
Newer quarter: Q4 2024
Previous quarter: Q2 2024
FATE THERAPEUTICS INC SEC filings
FATE THERAPEUTICS INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 31189P102
Recent filing periods:
Top shareholders of FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Redmile Group, LLC |
13F
|
Company |
11%
|
13,169,057
|
$43,194,507 | — | 30 Jun 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
8.6%
|
10,569,814
|
$34,668,990 | — | 30 Jun 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
8.3%
|
10,116,106
|
$33,180,827 | — | 30 Jun 2024 | |
| Boxer Capital, LLC |
13F
|
Company |
6.7%
|
8,215,910
|
$26,948,185 | — | 30 Jun 2024 | |
| Deep Track Capital, LP |
13F
|
Company |
4.6%
|
5,572,607
|
$18,278,151 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
4.4%
|
5,338,689
|
$17,510,900 | — | 30 Jun 2024 | |
| Bellevue Group AG |
13F
|
Company |
4%
|
4,839,779
|
$15,874,475 | — | 30 Jun 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
3.7%
|
4,488,026
|
$14,720,726 | — | 30 Jun 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
3.3%
|
4,077,922
|
$13,375,584 | — | 30 Jun 2024 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
2.9%
|
3,555,871
|
$11,663,257 | — | 30 Jun 2024 | |
| JOHNSON & JOHNSON |
13F
|
Company |
2.8%
|
3,379,064
|
$11,083,330 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
2.6%
|
3,147,989
|
$10,325,404 | — | 30 Jun 2024 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
2.5%
|
2,997,772
|
$9,832,692 | — | 30 Jun 2024 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
2.1%
|
2,574,703
|
$8,445,026 | — | 30 Jun 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.9%
|
2,348,554
|
$7,703,257 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.8%
|
2,247,383
|
$7,372,346 | — | 30 Jun 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.7%
|
2,130,280
|
$6,987,215 | — | 30 Jun 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
1.6%
|
2,008,862
|
$6,587,000 | — | 30 Jun 2024 | |
| Vestal Point Capital, LP |
13F
|
Company |
1.6%
|
2,000,000
|
$6,560,000 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.6%
|
1,985,732
|
$6,513,201 | — | 30 Jun 2024 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
1.4%
|
1,694,217
|
$5,557,032 | — | 30 Jun 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.3%
|
1,554,224
|
$5,097,855 | — | 30 Jun 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
1.2%
|
1,523,500
|
$4,997,080 | — | 30 Jun 2024 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
1.1%
|
1,355,352
|
$4,445,555 | — | 30 Jun 2024 | |
| Artal Group S.A. |
13F
|
Company |
0.84%
|
1,032,500
|
$3,386,600 | — | 30 Jun 2024 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.84%
|
1,031,505
|
$3,383,336 | — | 30 Jun 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.83%
|
1,019,987
|
$3,345,557 | — | 30 Jun 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.82%
|
1,002,002
|
$3,286,567 | — | 30 Jun 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.72%
|
879,375
|
$2,884,350 | — | 30 Jun 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.71%
|
870,000
|
$2,853,600 | — | 30 Jun 2024 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
0.71%
|
870,000
|
$2,853,600 | — | 30 Jun 2024 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
0.69%
|
850,000
|
$2,788,000 | — | 30 Jun 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.6%
|
736,674
|
$2,416,291 | — | 30 Jun 2024 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.57%
|
700,000
|
$2,296,000 | — | 30 Jun 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.45%
|
548,544
|
$1,799,224 | — | 30 Jun 2024 | |
| Octagon Capital Advisors LP |
13F
|
Company |
0.43%
|
520,800
|
$1,708,224 | — | 30 Jun 2024 | |
| SUPERSTRING CAPITAL MANAGEMENT LP |
13F
|
Company |
0.41%
|
497,360
|
$1,631,341 | — | 30 Jun 2024 | |
| GCM Grosvenor Holdings, LLC |
13F
|
Company |
0.41%
|
495,916
|
$1,626,604 | — | 30 Jun 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.37%
|
446,668
|
$1,465,071 | — | 30 Jun 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.31%
|
374,132
|
$1,227,153 | — | 30 Jun 2024 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.29%
|
356,101
|
$1,168,011 | — | 30 Jun 2024 | |
| E Fund Management Co., Ltd. |
13F
|
Company |
0.29%
|
355,225
|
$1,165,138 | — | 30 Jun 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.28%
|
345,575
|
$1,133,486 | — | 30 Jun 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.27%
|
330,082
|
$1,082,669 | — | 30 Jun 2024 | |
| Campbell & CO Investment Adviser LLC |
13F
|
Company |
0.27%
|
324,585
|
$1,064,639 | — | 30 Jun 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.26%
|
324,004
|
$1,062,732 | — | 30 Jun 2024 | |
| Bruce & Co., Inc. |
13F
|
Company |
0.25%
|
300,000
|
$984,000 | — | 30 Jun 2024 | |
| Monaco Asset Management SAM |
13F
|
Company |
0.23%
|
286,900
|
$941,032 | — | 30 Jun 2024 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.22%
|
264,467
|
$867,000 | — | 30 Jun 2024 | |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC |
13F
|
Company |
0.21%
|
262,414
|
$860,718 | — | 30 Jun 2024 |
Institutional Holders of FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) as of Q3 2024
As of 30 Sep 2024,
FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) was held by
157 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
114,626,757 shares.
The largest 10 holders included
Redmile Group, LLC, BlackRock, Inc., VANGUARD GROUP INC, Deep Track Capital, LP, STATE STREET CORP, Boxer Capital, LLC, Bellevue Group AG, CITADEL ADVISORS LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), and JOHNSON & JOHNSON.
This page lists
158
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
176
Q3 2024 holders
157
Holder diff
-19
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.